Allen Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Sell
21,855
-299
-1% -$24.1K 0.83% 28
2026
Q1
$1.92M Buy
22,154
+620
+3% +$59.4K 0.96% 23
2025
Q4
$2.07M Buy
21,534
+157
+0.7% +$15.3K 1.24% 19
2025
Q3
$2.04M Sell
21,377
-286
-1% -$26.3K 1.38% 15
2025
Q2
$1.89M Buy
21,663
+359
+2% +$30.4K 1.32% 15
2025
Q1
$1.91M Buy
21,304
+389
+2% +$34.8K 1.32% 16
2024
Q4
$1.67M Buy
20,915
+1,324
+7% +$115K 1.2% 18
2024
Q3
$1.76M Buy
19,591
+2,097
+12% +$176K 1.22% 21
2024
Q2
$1.38M Buy
17,494
+1,138
+7% +$93.3K 1.23% 20
2024
Q1
$1.43M Buy
+16,356
New +$1.4M 1.26% 20

Other funds holding MDT

Allen Wealth Management's MDT Position: Q2 2026 in Review

Allen Wealth Management reduced its Medtronic (MDT) stake by 1.3% in Q2 2026, selling an estimated $24.1K and leaving 21,855 shares worth $1.71M. The position accounts for 0.83% of the portfolio, ranked #28.

Allen Wealth Management first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.07M in Q4 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Allen Wealth Management held 21,855 shares of Medtronic worth $1.71M as of Q2 2026.
  • Allen Wealth Management sold 299 Medtronic shares in Q2 2026, an estimated $24.1K.
  • Medtronic made up 0.83% of Allen Wealth Management's portfolio in Q2 2026, its #28 holding.
  • Allen Wealth Management first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • Allen Wealth Management's Medtronic position peaked at $2.07M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Allen Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.